Lisa Schnirring | News Editor | CIDRAP NewsOct 16, 2020As the next steps, officials will conduct a meta-analysis of remdesivir studies, which experts will use to guide their latest treatment advice.
Large trial shows little benefit for remdesivir, pandemic total tops 39 million
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy